India, June 29 -- The share of this India-based pharmaceutical company, a leading player offering a portfolio of products and services including APIs, CPS, generics, biosimilars, and differentiated formulations, came into focus after USFDA approval and others.

With a market capitalization of Rs 1,17,936 crore, Dr Reddy's Laboratories Ltd's shares on Monday made a day high of Rs 1,414.40 per share, up by 4.7 percent from its previous day's close price of Rs 1.350 per share. The share of this company gave a return of 10 percent over the last 1 year. Factors that might be fueling investor sentiments

Shares gain despite US FDA observations The shares of Dr. Reddy's Laboratories gained in trade after investor sentiment improved despite the c...